Irinotecan and 5-fluorouracil in colorectal cancer: Time for a pause?

被引：5
|
作者：
Bulusu, VR [1 ]
机构：
[1] Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷 / 03期
关键词：
D O I：
10.1016/S0959-8049(97)10064-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：286 / 289
页数：4
相关论文
共 50 条
  • [31] Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer
    Yalcin, S
    Oksuzoglu, B
    Tekuzman, G
    Engin, H
    Celik, I
    Turker, A
    Barista, I
    Gullu, I
    Guler, N
    Altundag, K
    Ozisik, Y
    Kars, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 580 - 583
  • [32] Outpatient therapy with irinotecan and low-dose cisplatin for metastatic colorectal cancer resistant to 5-fluorouracil
    Shimada, S
    Yagi, Y
    Shiomori, K
    Kuramoto, M
    Aoki, N
    Ogawa, M
    ONCOLOGY REPORTS, 2002, 9 (04) : 783 - 787
  • [33] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [34] Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer
    Matsumoto, Hideo
    Okumura, Hideo
    Murakami, Haruaki
    Kubota, Hisako
    Higashida, Masaharu
    Tsuruta, Atsushi
    Tohyama, Kaoru
    Hirai, Toshihiro
    ANTICANCER RESEARCH, 2015, 35 (11) : 6193 - 6199
  • [35] Optimal use of the combination of irinotecan and 5-fluorouracil
    Benson, AB
    Goldberg, RM
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 68 - 77
  • [36] Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil
    Pfeiffer, P.
    Nielsen, D.
    Bjerregaard, J.
    Qvortrup, C.
    Yilmaz, M.
    Jensen, B.
    ANNALS OF ONCOLOGY, 2008, 19 (06) : 1141 - 1145
  • [37] Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study
    Kwon, Hyuk-Chan
    Oh, Sung Yong
    Lee, Suee
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (46) : 6231 - 6235
  • [38] Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer
    Matsusaka, Satoshi
    Yamasaki, Hajime
    Fukushima, Masakazu
    Wakabayashi, Ichiro
    CHEMOTHERAPY, 2007, 53 (01) : 36 - 41
  • [39] Bevacizumab plus infusional 5-fluorouracil,leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy:A pilot study
    Hyuk-Chan Kwon
    Sung Yong Oh
    Suee Lee
    Sung-Hyun Kim
    Hyo-Jin Kim
    World Journal of Gastroenterology, 2007, (46) : 6231 - 6235
  • [40] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Xie, Pan
    Mo, Jun-Luan
    Liu, Jin-Hong
    Li, Xi
    Tan, Li-Ming
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    CELLULAR ONCOLOGY, 2020, 43 (06) : 989 - 1001
12345